Psychotic symptoms in Parkinson's disease: pathophysiology and management.

about

Molecular imaging biomarkers for dementia with Lewy bodies: an update.Psychiatric side effects of non-psychiatric drugs.Cerebrospinal fluid biomarkers for dementia with lewy bodies.Pioglitazone use and Parkinson's disease: a retrospective cohort study in Taiwan

P2860

Q30881333-B462FB43-044F-4C51-B942-169AB56D8D0B Q34138808-7B7F3D7D-4936-4841-9F28-C51D7EF72959 Q34248241-5CA850ED-2B56-447F-9B46-28E92EB9416D Q58694525-2CDEDACF-A162-4D0B-BDE1-29C5F0A2B5BE

P2860

Psychotic symptoms in Parkinson's disease: pathophysiology and management.

Item

http://www.wikidata.org/entity/Q35779329

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Psychotic symptoms in Parkinson's disease: pathophysiology and management.

@ast

Psychotic symptoms in Parkinson's disease: pathophysiology and management.

@en

type

Item

label

Psychotic symptoms in Parkinson's disease: pathophysiology and management.

@ast

Psychotic symptoms in Parkinson's disease: pathophysiology and management.

@en

prefLabel

Psychotic symptoms in Parkinson's disease: pathophysiology and management.

@ast

Psychotic symptoms in Parkinson's disease: pathophysiology and management.

@en

P1476

Psychotic symptoms in Parkinson's disease: pathophysiology and management.

@en

P2093

Bosboom JL

http://www.w3.org/2001/XMLSchema#string

Wolters ECh

http://www.w3.org/2001/XMLSchema#string

P2860

Dopamine and the regulation of cognition and attention

Serotonin reuptake inhibitors, paranoia, and the ventral basal ganglia

Levodopa-induced psychosis: a kindling phenomenon

Olanzapine in the treatment of hallucinosis in idiopathic Parkinson's disease: a cautionary note

Risperidone treatment of drug-related psychosis in patients with parkinsonism

Worsening of motor features of parkinsonism with olanzapine

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

Prospective study of hallucinations and delusions in Parkinson's disease

Clozapine-induced agranulocytosis and thrombopenia in a patient with dopaminergic psychosis.

P304

209-220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.3.3.209

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15155149

http://www.w3.org/2001/XMLSchema#string

P921

psychosis

Psychotic symptoms in Parkinson's disease: pathophysiology and management.

about

P2860

P2860

Psychotic symptoms in Parkinson's disease: pathophysiology and management.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921